Showing results (291-300 of 328) with videos related to

Sort By:
Pageof 33
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995
Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and humanT Prueksaritanont, S K Balani, L M Dwyer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 24, 2005
Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormoneJörg B Engel, Gunhild Keller, Andrew V Schally, et al.
The Journal of Investigative Dermatology|July 10, 2001
Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotidesH Hegyesi, B Somlai, V L Varga, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activitiesMarta Zarandi, Jozsef L Varga, Andrew V Schally, et al.
Allergy|August 8, 2015
F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedemaM Speletas, Á Szilágyi, D Csuka, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 15, 2004
Identification and quantitation of extractables from cellulose acetate butyrate (CAB) and estimation of their in vivo exposure levelsDecheng Ma, Walter R Wasylaschuk, Christopher Beasley, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2005
Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormoneGunhild Keller, Andrew V Schally, Kate Groot, et al.
Journal of Medicinal Chemistry|April 1, 1987
Thienothiopyran-2-sulfonamides: a novel class of water-soluble carbonic anhydrase inhibitorsG S Ponticello, M B Freedman, C N Habecker, et al.
Pageof 33